. Donepezil-associated survival benefits among Alzheimer's disease patients are retained but not enhanced during COVID-19 infections. Ther Adv Infect Dis. 2023;10:20499361231174289. Epub 2023 May 22 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.